STEP BY STEP, BUILDING STRONGER HEALTHCARE SYSTEMS
The result: a series of pilot programmes that demonstrate the power of concrete solutions to improve the sustainability of healthcare systems. Each programme falls under at least one of the three pillars of sustainable healthcare: prevention and early intervention, patient empowerment and reorganisation of care delivery. The most successful pilots are scaled up and every project proves that even small changes have the potential to make a big impact. The power of pilot programmes is that they serve as examples; models that can be adapted to different countries, languages and health systems.
- Austria – Psoriasis Patient Coaches
- Belgium – Activ84worK
- Canada – Alberta gets Fit for Work
- Denmark – A Solution Catalogue with nine solutions
- Finland – Advancing Healthcare Sustainability
- France – Carmelia
- Germany – The “Simply Irreplaceable!” Initiative
- Greece – Instituting National Health Insurance
- Greece – Re-organising Emergency Hospital Care
- Ireland – A Journey of Innovation & Partnership
- Israel – Reboot – AbbVie Innovation Forum
- Italy – A Micro-Simulation Model
- Netherlands – Towards more Effective Treatments
- Norway – “We Care!” A Work/Life Balance Initiative
- Poland – “Healthy – Active – Constructive”
- Portugal – IS2 Portugal Sustainable Health Initiative
- Romania – The “Hands with Life” Initiative
- Slovakia – A study to facilitate patient education
- Spain – Fit for Life: Living longer, Living Better
- Sweden – A Solutions Catalogue
- Sweden: IBD Home – Patient disease self-monitoring
- Switzerland – Development for Hospitals: A Manual
- Turkey – Gaziantep University Early Arthritis Clinic
- UK – The Hepatitis C Partnership
- UK – The Shared Decision-Making Tool
- UK – Early Intervention Clinic for MSDs
Slovakia – A study to facilitate patient education
By conducting a study in autoimmune diseases (ADs) such as Psoriasis, Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PA), AbbVie Slovakia and AbbVie Czech republic partnered with patients, patient organisations and academia to inform and empower patients in the fields of Health Technology Assessments (HTAs) and Quality of Life (QoL) to improve treatment and decision-making processes.
The project’s scope included conducting the study and facilitating a patient education programme with clinical experts and academia on ADs, their impact on workability, QoL and put forth potential solutions to challenges facing people living with ADs.
Chronic ADs, especially RA, have negative impacts on activities of daily living and the most commonly reported symptoms are fatigue and pain. Functional status worsens with the duration of disease. The occurrence of permanent work disability and sick leave was substantial in the sample. The study of patients with RA showed significant impact of disease on work capabilities and socio-economic status.
Data on work productivity lost in patients with moderate and severe Psoriasis showed that the main cost impact is caused by absenteeism and presenteeism. The productivity costs in Czech Republic alone are as high as 4 billion euros per year. There is also significant impact on daily activities.
Societal consequences of not implementing the patients in decision processes are huge. Autoimmune diseases as a group are among the most costly diseases faced by society today. Research has shown that patient participation leads to higher judgments of the quality of care and patient participation leads to greater self-efficacy in patients, which leads to better health outcomes. For all that reasons we need the empowered patients, which can be only educated patients.
The Project should help empower patients to be informed and become part of the decision-making process in the treatment and care of their chronic condition.
The benefits of such a project include better understanding of and coping with the disease for patients, improved QoL and access to treatment, more motivated patients taking on the role of expert ambassadors for their communities and supporting other patients within Patient Organisations, physicians seeing better educated and motivated patients who adhere better to their therapy and enjoy an improved QoL, and the health and social systems benefiting from reduced costs for avoidable treatment of co-morbidities. This project is wholly replicable in other countries
Spotlight on Prevention: When, Who and How?
Unhealthy lifestyles and lack of physical activity are key factors in the development of chronic diseases. Early prevention and diagnosis, better education, and above all collaboration among governments, patient organizations, and industry are crucial to prevent chronic diseases from arising.